Clinical Trial Update: InSync Implantable Cardioverter Defibrillator Registry: Cardiac Resynchronization Therapy

View source ↗

Summary

The InSync Implantable Cardioverter Defibrillator Registry study evaluating Cardiac Resynchronization Therapy in heart failure and cardiomyopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Heart Failure

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Heart Failure, Cardiomyopathy | Status: COMPLETED